E-LIB Suche - Ergebnisse für: Sculpher, Mark

1

Cefiderocol for treating severe aerobic Gram-negative bacte..:

Woods, Beth ; Schmitt, Laetitia ; Jankovic, Dina...
Health Technology Assessment. , 2024

Link: https://doi.org/10.3310/..

2

Achieving dynamic efficiency in pharmaceutical innovation: ..:

Woods, Beth ; Lomas, James ; Sculpher, Mark..
Health Economics. 33 (2024) 4 - p. 804-819 , 2024

Link: https://doi.org/10.1002/..

3

Percutaneous Revascularization for Ischemic Left Ventricula..:

Chivardi, Carlos ; Morgan, Holly ; Sculpher, Mark J....
Circulation: Cardiovascular Quality and Outcomes. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1161/..

4

A framework for conducting economic evaluations when using ..:

Roberta Ara ; John Brazier ; Mark Sculpher...
doi:10.15131/shef.data.25218902.v1. , 2024

Link: https://doi.org/10.15131..

5

Getting cost-effective technologies into practice: the valu..:

Rita Faria ; Simon Walker ; Sophie Whyte...
doi:10.15131/shef.data.25013228.v1. , 2024

Link: https://doi.org/10.15131..

6

SUPPORTING THE ROUTINE COLLECTION OF PATIENT REPORTED OUTCO..:

Roberta Ara ; Ana Duarte ; Sue Harnan...
doi:10.15131/shef.data.25118669.v1. , 2024

Link: https://doi.org/10.15131..

7

SUPPORTING THE ROUTINE COLLECTION OF PATIENT REPORTED OUTCO..:

Roberta Ara ; Ana Duarte ; Sue Harnan...
doi:10.15131/shef.data.25118552.v1. , 2024

Link: https://doi.org/10.15131..

8

Getting cost-effectiveness technologies into practice: the ..:

Munira Essat ; Rita Faria ; Timothy Gomersall...
doi:10.15131/shef.data.25003247.v1. , 2024

Link: https://doi.org/10.15131..

9

A rapid review of the cost-effectiveness of alternative int..:

Roberta Ara ; Barbieri, M ; Helen Weatherly...
doi:10.15131/shef.data.25012634.v1. , 2024

Link: https://doi.org/10.15131..

10

Evidence for the impact of interventions for, and medicines..:

Rita Faria ; Marrissa Martyn-St James ; Ruth Wong..
doi:10.15131/shef.data.25219142.v1. , 2024

Link: https://doi.org/10.15131..

11

SUPPORTING THE ROUTINE COLLECTION OF PATIENT REPORTED OUTCO..:

Roberta Ara ; Ana Duarte ; Sue Harnan...
doi:10.15131/shef.data.25118675.v1. , 2024

Link: https://doi.org/10.15131..

12

SUPPORTING THE ROUTINE COLLECTION OF PATIENT REPORTED OUTCO..:

Roberta Ara ; Ana Duarte ; Sue Harnan...
doi:10.15131/shef.data.25118576.v1. , 2024

Link: https://doi.org/10.15131..

13

Cost-effectiveness analysis of genomic tests: what are the ..:

Eldon Spackman ; Sebastian Hinde ; Laura Bojke..
doi:10.15131/shef.data.25118534.v1. , 2024

Link: https://doi.org/10.15131..

14

SUPPORTING THE ROUTINE COLLECTION OF PATIENT REPORTED OUTCO..:

Roberta Ara ; Ana Duarte ; Sue Harnan...
doi:10.15131/shef.data.25118573.v1. , 2024

Link: https://doi.org/10.15131..

15

SUPPORTING THE ROUTINE COLLECTION OF PATIENT REPORTED OUTCO..:

Roberta Ara ; Ana Duarte ; Sue Harnan...
doi:10.15131/shef.data.25118552.v1. , 2024

Link: https://doi.org/10.15131..